Creative Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86.9M Buy
246,914
+23,462
+10% +$8.36M 0.06% 144
2025
Q4
$73.1M Buy
223,452
+19,897
+10% +$6.31M 0.05% 155
2025
Q3
$57.4M Sell
203,555
-11,231
-5% -$3.26M 0.04% 167
2025
Q2
$60M Sell
214,786
-7,253
-3% -$2.05M 0.05% 147
2025
Q1
$69.2M Buy
222,039
+23,485
+12% +$6.94M 0.07% 123
2024
Q4
$51.8M Buy
198,554
+1,097
+0.6% +$325K 0.05% 143
2024
Q3
$63.4M Buy
197,457
+14,864
+8% +$4.86M 0.06% 119
2024
Q2
$57.1M Buy
182,593
+14,082
+8% +$4.14M 0.06% 119
2024
Q1
$47.9M Buy
168,511
+6,082
+4% +$1.78M 0.05% 137
2023
Q4
$46.8M Buy
162,429
+4,020
+3% +$1.1M 0.09% 128
2023
Q3
$42.6M Buy
158,409
+15,216
+11% +$3.8M 0.06% 139
2023
Q2
$31.8M Buy
143,193
+3,660
+3% +$849K 0.04% 164
2023
Q1
$33.7M Sell
139,533
-2,053
-1% -$504K 0.05% 151
2022
Q4
$37.2M Buy
141,586
+11,797
+9% +$3.16M 0.06% 134
2022
Q3
$29.3M Sell
129,789
-7,759
-6% -$1.88M 0.05% 141
2022
Q2
$33.5M Buy
137,548
+27,384
+25% +$6.71M 0.06% 137
2022
Q1
$26.6M Sell
110,164
-998
-0.9% -$229K 0.04% 167
2021
Q4
$25M Sell
111,162
-3,803
-3% -$803K 0.04% 160
2021
Q3
$24.4M Sell
114,965
-2,580
-2% -$594K 0.04% 158
2021
Q2
$28.7M Buy
117,545
+6,764
+6% +$1.66M 0.05% 136
2021
Q1
$27.6M Buy
110,781
+2,456
+2% +$586K 0.06% 133
2020
Q4
$24.9M Sell
108,325
-213
-0.2% -$49.1K 0.05% 140
2020
Q3
$27.6M Buy
108,538
+8,347
+8% +$2.07M 0.07% 108
2020
Q2
$23.6M Sell
100,191
-2,887
-3% -$659K 0.07% 106
2020
Q1
$20.9M Sell
103,078
-3,107
-3% -$679K 0.07% 107
2019
Q4
$25.6M Buy
106,185
+3,649
+4% +$804K 0.08% 103
2019
Q3
$19.8M Sell
102,536
-1,933
-2% -$371K 0.06% 120
2019
Q2
$19.3M Buy
104,469
+5,351
+5% +$958K 0.06% 119
2019
Q1
$18.8M Sell
99,118
-575
-0.6% -$110K 0.07% 109
2018
Q4
$19.4M Buy
99,693
+2,415
+2% +$471K 0.08% 96
2018
Q3
$20.2M Buy
97,278
+4,257
+5% +$839K 0.07% 99
2018
Q2
$17.2M Buy
93,021
+4,727
+5% +$836K 0.07% 103
2018
Q1
$15.1M Sell
88,294
-8,013
-8% -$1.47M 0.06% 112
2017
Q4
$16.7M Buy
96,307
+8,391
+10% +$1.48M 0.07% 105
2017
Q3
$16.4M Sell
87,916
-2,490
-3% -$441K 0.08% 107
2017
Q2
$15.6M Buy
90,406
+22,280
+33% +$3.62M 0.08% 103
2017
Q1
$11.2M Sell
68,126
-16,207
-19% -$2.69M 0.06% 115
2016
Q4
$12.3M Buy
84,333
+9,139
+12% +$1.38M 0.08% 105
2016
Q3
$12.5M Buy
75,194
+8,019
+12% +$1.36M 0.08% 106
2016
Q2
$10.2M Buy
67,175
+3,503
+6% +$545K 0.07% 106
2016
Q1
$9.55M Buy
63,672
+1,125
+2% +$167K 0.07% 101
2015
Q4
$10.2M Buy
62,547
+3,254
+5% +$511K 0.08% 102
2015
Q3
$8.2M Buy
59,293
+2,079
+4% +$328K 0.07% 113
2015
Q2
$8.78M Buy
57,214
+273
+0.5% +$43.7K 0.08% 105
2015
Q1
$9.1M Buy
56,941
+887
+2% +$140K 0.09% 98
2014
Q4
$8.93M Buy
56,054
+8,538
+18% +$1.33M 0.09% 103
2014
Q3
$6.67M Buy
47,516
+4,720
+11% +$616K 0.08% 112
2014
Q2
$5.07M Sell
42,796
-35,894
-46% -$4.16M 0.07% 122
2014
Q1
$9.71M Sell
78,690
-61,800
-44% -$7.5M 0.15% 71
2013
Q4
$16M Sell
140,490
-8,634
-6% -$982K 0.27% 45
2013
Q3
$16.7M Buy
149,124
+107,529
+259% +$11.7M 0.33% 35
2013
Q2
$4.1M Buy
+41,595
New +$4.32M 0.1% 87

Other funds holding AMGN

Creative Planning's AMGN Position: Q1 2026 in Review

Creative Planning increased its Amgen (AMGN) stake by 10% in Q1 2026, buying an estimated $8.36M and bringing the position to 246,914 shares worth $86.9M. The position accounts for 0.06% of the portfolio, ranked #144.

Creative Planning first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Creative Planning held 246,914 shares of Amgen worth $86.9M as of Q1 2026.
  • Creative Planning bought 23,462 Amgen shares in Q1 2026, an estimated $8.36M.
  • Amgen made up 0.06% of Creative Planning's portfolio in Q1 2026, its #144 holding.
  • Creative Planning first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.